Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial.
about
Dietary and nutritional considerations for inflammatory bowel diseaseTreatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitisTreatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitisProbiotics for maintenance of remission in Crohn's diseaseProbiotics for the maintenance of remission in Crohn's diseaseFrom structure to function: the ecology of host-associated microbial communitiesSynbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trialMaintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazineDysbiosis in inflammatory bowel diseaseProbiotic prophylaxis in patients with predicted severe acute pancreatitis (PROPATRIA): design and rationale of a double-blind, placebo-controlled randomised multicenter trial [ISRCTN38327949]Modulating Composition and Metabolic Activity of the Gut Microbiota in IBD PatientsDiet therapy for inflammatory bowel diseases: The established and the newMicrobiota Manipulation With Prebiotics and Probiotics in Patients Undergoing Stem Cell TransplantationTh17 Cells as Potential Probiotic Therapeutic Targets in Inflammatory Bowel DiseasesThe gut microbiota and host health: a new clinical frontierThe Intestinal Microbiota in Inflammatory Bowel DiseaseProbiotic-based strategies for therapeutic and prophylactic use against multiple gastrointestinal diseasesUse of Biologics in Pouchitis: A Systematic ReviewGut microbial flora, prebiotics, and probiotics in IBD: their current usage and utilityThe role of antibiotics and probiotics in pouchitisIntestinal microbiota in health and disease: role of bifidobacteria in gut homeostasisProbiotics in inflammatory bowel diseases and associated conditionsIntestinal permeability--a new target for disease prevention and therapyEnteric bacterial proteases in inflammatory bowel disease- pathophysiology and clinical implicationsModulation of microbiota as treatment for intestinal inflammatory disorders: An uptodateMatrix metalloproteinases in inflammatory bowel disease: an updateProbiotic treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial with Lactobacillus acidophilus and Bifidobacterium animalis subsp. LactisSystematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel diseaseMicrobiota-induced activation of epithelial IL-6 signaling links inflammasome-driven inflammation with transmissible cancerThe human microbiome and probiotics: implications for pediatricsHelminths as therapeutic agents for inflammatory bowel diseaseMedical management of Crohn's disease: current therapy and recent advances.Review article: bifidobacteria as probiotic agents -- physiological effects and clinical benefits.Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis.Supplementation of the diet with high-viscosity beta-glucan results in enrichment for lactobacilli in the rat cecum.Review article: the role of bacteria in onset and perpetuation of inflammatory bowel disease.Identification of a putative operon involved in fructooligosaccharide utilization by Lactobacillus paracaseiEffect of oral lactulose on clinical and immunohistochemical parameters in patients with inflammatory bowel disease: a pilot study.Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases.Post-translational inhibition of IP-10 secretion in IEC by probiotic bacteria: impact on chronic inflammation.
P2860
Q22251396-3667A8AE-C279-444D-89AD-BA51A3B70547Q24187707-FA8220F2-03AC-4A34-BDC0-EFE1ABE2C7F4Q24234806-6289FE1A-AB67-43B8-9BFB-3F22216AEC8CQ24244110-E09A59D3-C095-4915-AA8C-36C36C76BB4EQ24246901-DDB41810-C16B-47AC-A8FC-8790166B6DB1Q24612050-42F09914-F63F-47A7-B8B4-DE36BF7FF7FEQ24685494-F62DB46D-477A-4CA0-8560-7E4FC9F7692FQ24685766-90B1B4FF-E7D6-47A2-8E4D-347FD5280A9AQ24685931-751BE538-CEED-4E3C-AF72-913D379E163FQ24791550-AD91FD22-E196-4417-827D-ECA598295994Q26750985-672D77A3-B976-474F-88A4-BC87A48E3E2EQ26768564-19411E88-0CB7-4D2E-943A-4E6A28187195Q26771287-6669B5E1-9B41-463F-AEE9-B03A156EE606Q26784194-48C9BA47-FB82-495A-A333-9A1A268FA727Q26785649-359AE28E-ABD7-497B-8DFD-D649196C15D5Q26795705-89DA8F23-FE58-4015-96F0-377EAE2FA692Q26800020-932CCEC4-C2BE-4DCD-90D0-B8E98FD3D378Q26995117-098C36BD-F5B7-4004-96BD-10FD3F0B6F55Q26995672-26A2B9A4-7C28-4EEA-AC0C-45CC2CDCD610Q27000314-15CAC46A-C7E6-415B-BB62-A172E3385480Q27001712-2DCCBA95-80B4-432B-9A27-C6A04518774FQ27002496-8DB30182-AE78-4FA0-886F-1C114BFD3E08Q27015884-C30B88D8-8C25-42C2-94FC-5D7347435AA0Q27027602-6442773B-AF88-45BD-9423-E76EA50400E9Q28072437-0F146F23-6009-4D43-91E1-EA88FE51EF35Q28080664-CB97A083-6D0E-410A-ABC0-5E7E6016F2C9Q28238046-931E60D8-C721-47B4-B50F-DCC1681AE871Q28254207-9E71C5C7-78B1-4D41-8E95-88275D173B2BQ28592907-68A610AD-C575-4B9D-9D42-1A46AD312961Q28750959-FCC45E65-74F1-44B6-AFDE-130866661F07Q29011405-8D348973-EC61-4826-B5E2-DABE8864164EQ30450875-21C3B88D-D589-48A0-BA04-FDEACD122E11Q33223485-8C805965-65A0-429D-A1E2-8D295BD2BBABQ33231186-518A5172-FB67-4A1E-9135-F6EDDAC01BBBQ33235512-29B80582-E345-4A03-9CA0-CD6E95EA2DBAQ33256876-1CC556EB-8FF6-48EF-A4C6-45A8B3FD6D3CQ33259728-F6387547-2DE0-4BEE-920A-51FDD7422B27Q33296911-B02DB230-F7FE-4BF8-AEE8-7D20018C2421Q33341563-02828B85-ED46-4941-A188-3F8FB8EF70D1Q33406281-CB61C329-5576-4173-95C0-52C8F4AE9961
P2860
Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Prophylaxis of pouchitis onset ...... ind, placebo-controlled trial.
@en
Prophylaxis of pouchitis onset ...... ind, placebo-controlled trial.
@nl
type
label
Prophylaxis of pouchitis onset ...... ind, placebo-controlled trial.
@en
Prophylaxis of pouchitis onset ...... ind, placebo-controlled trial.
@nl
prefLabel
Prophylaxis of pouchitis onset ...... ind, placebo-controlled trial.
@en
Prophylaxis of pouchitis onset ...... ind, placebo-controlled trial.
@nl
P2093
P50
P1433
P1476
Prophylaxis of pouchitis onset ...... ind, placebo-controlled trial.
@en
P2093
Alessandro Venturi
Beatrice Vitali
Gilberto Poggioli
Karen Manon Lammers
Mario Miglioli
Ulf Helwig
P304
P356
10.1016/S0016-5085(03)00171-9
P407
P577
2003-05-01T00:00:00Z